XML 56 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss per Share (Tables)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss per Share of Class A Common Stock

F-26

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of Class A Common Stock is as follows (amounts in thousands, except per share amounts):

 

 

Year Ended December 31,

 

 

2021

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(17,731

)

 

$

(12,802

)

 

$

(21,938

)

Less: Net loss attributable to noncontrolling interests

 

(4,744

)

 

 

(4,303

)

 

 

(8,894

)

Net loss attributable to vTv Therapeutics Inc.

 

(12,987

)

 

 

(8,499

)

 

 

(13,044

)

Less: Deemed distribution to related party (Note 13)

 

 

 

 

 

 

 

(4,869

)

Net loss attributable to common shareholders of vTv Therapeutics Inc.,

   basic and diluted

$

(12,987

)

 

$

(8,499

)

 

$

(17,913

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted average vTv Therapeutics Inc. Class A Common

   Stock, basic and diluted

 

60,732,636

 

 

 

47,137,917

 

 

 

30,292,030

 

Net loss per share of vTv Therapeutics Inc. Class A

   Common Stock, basic and diluted

$

(0.21

)

 

$

(0.18

)

 

$

(0.59

)

 

Schedule of Potentially Dilutive Securities not Included in Calculation of Dilutive Net Loss per Share

Potentially dilutive securities not included in the calculation of dilutive net loss per share are as follows:

 

 

Year Ended December 31,

 

 

2021

 

 

2020

 

 

2019

 

Class B Common Stock (1)

 

23,093,860

 

 

 

23,094,221

 

 

 

23,094,221

 

Common stock options granted under the Plan

 

7,056,035

 

 

 

4,453,357

 

 

 

2,531,143

 

Restricted stock units

 

 

 

 

 

 

 

11,667

 

Common stock options granted under the Letter Agreement

 

 

 

 

 

 

 

6,250,000

 

Common stock warrants

 

2,014,503

 

 

 

2,014,503

 

 

 

2,014,503

 

Total

 

32,164,398

 

 

 

29,562,081

 

 

 

33,901,534

 

 

 

 

(1)

Shares of Class B Common Stock do not share in the Company’s earnings and are not participating securities.  Accordingly, separate presentation of loss per share of Class B Common Stock under the two-class method has not been provided.  Each share of Class B Common Stock (together with a corresponding vTv Unit) is exchangeable for one share of Class A Common Stock.